Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice.

Ricardo Ruiz VillaverdeEnrique Herrera-AcostaAndres Ruiz de CasasIsabel M Villegas-RomeroFátima G Moreno-SuárezFrancisco Vílchez-MárquezManuel Galán-GutiérrezMaria Carmen Vázquez-BayoSandra Cases-MéridaFrancisco M Almazán-Fernández

Published in: Journal of clinical medicine (2023)

Sonidegib is the second iHh authorized for the treatment of adult patients with locally advanced BCC who are not amenable to curative surgery or radiotherapy, based on the results of the phase II clinical trial, BOLT. Sonidegib shows good effectiveness and an acceptable safety profile in routine clinical practice in the sample presented.

Keyphrases

clinical practice
clinical trial
phase ii
locally advanced
rectal cancer
open label
squamous cell carcinoma
randomized controlled trial
minimally invasive
radiation therapy
systematic review
early stage
study protocol
coronary artery disease
combination therapy
acute coronary syndrome
phase iii